Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of intranodular adalimumab in early Dupuytren's disease
2015-001780-40Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Apr 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dupuytren's contracture comparing Adalimumab intranodular injection with Placebo intranodular injection (2 arms). Primary endpoint: Expression of alpha-smooth muscle actin mRNA. Status: unknown.
02
Drugs
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2015-001780-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001780-40.